Literature DB >> 20590665

Differential proteome and phosphoproteome signatures in human T-lymphoblast cells induced by sirolimus.

F C Schultze1, D T Petrova, M Oellerich, V W Armstrong, A R Asif.   

Abstract

OBJECTIVES: The present study was designed to investigate early proteome and phosphoproteome changes during inhibition of lymphocyte proliferation induced by sirolimus (SRL).
MATERIALS AND METHODS: Proliferation assays were conducted using human CCRF-CEM T lymphoblasts under different SRL concentrations. Total protein lysates after SRL treatment were used to identify significantly regulated proteins and phosphorylated proteins by 2-DE and Q-TOF Ultima Global mass spectrometer. RESULTS AND
CONCLUSIONS: Incubation with 2.5 micromol/l SRL resulted in a approximately 70% inhibition of cell proliferation. Cells incubated with 2.5 micromol/l for 30 min showed a differential phosphorylation pattern with one higher (TCPQ) and six lower phosphorylation signals (TBA1B, VIME, HNRPD, ENPL, SEPT9, PLSL). On investigating the differential protein expression, five proteins were found to be up-regulated (ECHB, PSB3, MTDC, LDHB and NDKA) and four were down-regulated (EHD1, AATC, LMNB1 and MDHC). Nine of these differentially regulated proteins/phosphoproteins (TCPQ, TBA1B, VIME, HNRPD, ENPL, ECHB, PSB3, LDHB and LMNB1) showed significant interaction potential, through binding protein YWHAZ using MINT software.
CONCLUSIONS: We report for the first time the simultaneous early influence of SRL on phosphorylation status and on protein expression in the total proteome of CCRF-CEM T lymphoblasts and predict that 56% of the proteins interact with each other, highlighting significance of these results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590665      PMCID: PMC6496580          DOI: 10.1111/j.1365-2184.2010.00690.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  34 in total

1.  14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain.

Authors:  T Ogihara; T Isobe; T Ichimura; M Taoka; M Funaki; H Sakoda; Y Onishi; K Inukai; M Anai; Y Fukushima; M Kikuchi; Y Yazaki; Y Oka; T Asano
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

2.  Grp94 is Tyr-phosphorylated by Fyn in the lumen of the endoplasmic reticulum and translocates to Golgi in differentiating myoblasts.

Authors:  Martina Frasson; Maurizio Vitadello; Anna Maria Brunati; Nicoletta La Rocca; Elena Tibaldi; Lorenzo A Pinna; Luisa Gorza; Arianna Donella-Deana
Journal:  Biochim Biophys Acta       Date:  2008-10-22

3.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

4.  Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.

Authors:  B J Rensing; J Vos; P C Smits; D P Foley; M J van den Brand; W J van der Giessen; P J de Feijter; P W Serruys
Journal:  Eur Heart J       Date:  2001-11       Impact factor: 29.983

5.  Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway.

Authors:  H Leffers; P Madsen; H H Rasmussen; B Honoré; A H Andersen; E Walbum; J Vandekerckhove; J E Celis
Journal:  J Mol Biol       Date:  1993-06-20       Impact factor: 5.469

6.  Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.

Authors:  Biplab Dasgupta; Yijun Yi; David Y Chen; Jason D Weber; David H Gutmann
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

7.  Identification of 14-3-3zeta as a protein kinase B/Akt substrate.

Authors:  David W Powell; Madhavi J Rane; Qingdan Chen; Saurabh Singh; Kenneth R McLeish
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

Review 8.  Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents.

Authors:  Ravi D Rao; Jan C Buckner; Jann N Sarkaria
Journal:  Curr Cancer Drug Targets       Date:  2004-12       Impact factor: 3.428

Review 9.  Sirolimus in renal transplantation.

Authors:  Christian Morath; Wolfgang Arns; Vedat Schwenger; Arianeb Mehrabi; Hamidreza Fonouni; Jan Schmidt; Martin Zeier
Journal:  Nephrol Dial Transplant       Date:  2007-09       Impact factor: 5.992

10.  T-786C polymorphism of the NOS-3 gene and the endothelial cell response to fluid shear stress-a proteome analysis.

Authors:  Abdul R Asif; Michael Oellerich; Victor William Armstrong; Markus Hecker; Marco Cattaruzza
Journal:  J Proteome Res       Date:  2009-06       Impact factor: 4.466

View more
  7 in total

Review 1.  Are snoRNAs and snoRNA host genes new players in cancer?

Authors:  Gwyn T Williams; Farzin Farzaneh
Journal:  Nat Rev Cancer       Date:  2012-01-19       Impact factor: 60.716

2.  La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1).

Authors:  Bruno D Fonseca; Chadi Zakaria; Jian-Jun Jia; Tyson E Graber; Yuri Svitkin; Soroush Tahmasebi; Danielle Healy; Huy-Dung Hoang; Jacob M Jensen; Ilo T Diao; Alexandre Lussier; Christopher Dajadian; Niranjan Padmanabhan; Walter Wang; Edna Matta-Camacho; Jaclyn Hearnden; Ewan M Smith; Yoshinori Tsukumo; Akiko Yanagiya; Masahiro Morita; Emmanuel Petroulakis; Jose L González; Greco Hernández; Tommy Alain; Christian K Damgaard
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

3.  MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes.

Authors:  Yevgeniy A Grigoryev; Sunil M Kurian; Traver Hart; Aleksey A Nakorchevsky; Caifu Chen; Daniel Campbell; Steven R Head; John R Yates; Daniel R Salomon
Journal:  J Immunol       Date:  2011-07-25       Impact factor: 5.422

4.  Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinoma.

Authors:  Marta Wójcik; Pierluigi Ramadori; Martina Blaschke; Sadaf Sultan; Sajjad Khan; Ihtzaz A Malik; Naila Naz; Gesa Martius; Giuliano Ramadori; Frank C Schultze
Journal:  Histochem Cell Biol       Date:  2011-12-01       Impact factor: 4.304

5.  Crosstalk between Edc4 and mammalian target of rapamycin complex 1 (mTORC1) signaling in mRNA decapping.

Authors:  Hazir Rahman; Muhammad Qasim; Michael Oellerich; Abdul R Asif
Journal:  Int J Mol Sci       Date:  2014-12-12       Impact factor: 5.923

6.  Effects of mycophenolate mofetil on kidney function and phosphorylation status of renal proteins in Alport COL4A3-deficient mice.

Authors:  Darinka Todorova Petrova; Frank Christian Schultze; Gunnar Brandhorst; Klaus-Dieter Luchs; Christof Lenz; Henning Urlaub; Diana Rubel; Oliver Gross; Philip D Walson; Michael Oellerich
Journal:  Proteome Sci       Date:  2014-12-10       Impact factor: 2.480

7.  Associations among ancestry, geography and breast cancer incidence, mortality, and survival in Trinidad and Tobago.

Authors:  Wayne A Warner; Robert L Morrison; Tammy Y Lee; Tanisha M Williams; Shelina Ramnarine; Veronica Roach; Simeon Slovacek; Ravi Maharaj; Nigel Bascombe; Melissa L Bondy; Matthew J Ellis; Adetunji T Toriola; Allana Roach; Adana A M Llanos
Journal:  Cancer Med       Date:  2015-09-04       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.